We would love to hear your thoughts about our site and services, please take our survey here.
95p won't be no where to seen once the RNSs start coming, never mind be a resistance point lol
NASDAQ was at the equivalent if 88p at one point today, so interest seems to be peekibg across the pond.
Indeed Chris, still very cheap with all the news due. Not much left of Q4 now
"However, even if someone like Dave places little weight on the presentation as a source of insight, it is official communication by the company and management have a duty not to knowingly mislead investors."
Boonco there is a big difference between havibg price sensitive in a prsentation, as opposed to General investor information!!! Guidances on readout timelines are not price sensitive, however trial data is.
Should have been £1+ before the newsflow even commenced, if it wasn't for the distressed seller and the delay in news.
Gone into auction now, could be an interesting afternoon.
Bigyellowpig-if you have history with Porky, take it elsewhere. Don't be spamming on here
"Then you claimed that it's obvious 0518 Keytruda trial wasn't going well (how do you know?) and you called Boonco names. Now you are sure that we'll have 5 pieces of news by the end of the year. I do question the credibility of the Twitter post, by the way, given that the official 4D announcement talks about Q1 2021!"
Michael, my comment was based on the fact the interim data was due in June, and then late Summer but still never arrived. Being an open label trial the data could be reported anytime, so it was obvious there was some issues hence the delay. It doesn't mean it will be delayed forever. You obviously haven't read the latrst investor presentation, which was released last month. ALL catalyst are confirmed for Q4, so you're statement earlier about recieving one RNS a month for each of the five catalyst until March 2021 is a load of nonsense. The Twitter post is just a screenshot from 4D's own investor presentation last month, yet you still question the validity of it? Read the investor presentation pal.
Porky they need to grow up and accept responsibility for their own actions. They chose to sell up and make money elsewhere, it didn't work out and now have to potentially buy in higher than they sold. Misleading facts, scare mongering is their way of trying to secure a cheaper entry.
I'm neither impatient or desperate. All i'm doing is setting the record straight, as you and your pals seem to be spreading false information. Everything I have quoted is from the investor presentation, so why are you guys going around there is no news until late/mid Q1? Just because you and staylong chose to sellup and now the SP has moved, you took the gamble and now take responsibility for your own actions rather deramping.
Staylong another one desperately trying to get back in. Please see his post on 26th October after he sold at 62p:
"I believe that I can make my money move quicker elsewhere for the next 6 weeks."
His trade elsewhere obviously hasn't worked out, and now trying to avoid getting back in higher than he sold lol. Certainly don't live up to your name fo you Staylong?
With regards to the Catalysts, please don't fall for the derampers telling you it's once RNS a month until March, or all readouts due in Q1. Please see the tweet below which has the slide from 4D's incestor presebtation confirming when the news is due.
https://twitter.com/Brabo83/status/1455963790768488452?t=-Z1rm0OV4jrf0fEQA3pkHg&s=19
Further more 4D have confirmed via email in mid October, ALL this news will be out by mid Jan at the latest. 5 RNS due in a maximum of 8 weeks, which could drop anytime. FOMO will start kicking in, and these prices will look cheap as chips. This will see one hell of a rerate here.
"The news you list is expected any time between now and in the course of next FIVE months (i.e. end of Q1 2022) according the the company. So not sure where you get the three weeks or end of the year from."
Michael this is incorrect. I suggest you look at the investor presentation, ALL items will be reported on before the end of the year, 2 may slip into the first week of January. You can also email 4D IR who have confirmed this for many, and was also on Twitter a while ago. Don't make assumptions if you are unsure.
Of course you were "being sarcastic", you got you quick 10% trade yesterday. This share will fly on multiple positive pieces of news, which are all due before the year is out. No chance of buying at these levels then, the SP will be closer to £2.
Coldbrew he has consistently changed his view according to his position at the time. Don't come ramping on here for your 10%, and then switch to deramping to get an entry again. This is the issue most have with Sang, it's immoral and unproductive. Even if there is a fundraise he will be higher from where management threw in £2m at £1.10 just 6 months ago, but Sang would have you believe it will be from tgese depressed levels. Management will have to think very carefully before any fundraise and ensure it's a value driver, as otherwise their reputation will be blown, not too mebtion the millions of their own money they have already pumped into thus business.
Cwalsh was trying to ramp with a product that doesn't even belong to GDR a few days ago lol. Sally probably remortgaging her house to invest in GDR , as it's a 100 bagger here from her £24 a share target lol. Obvioulsy been taking advice from her Black dog. And then you have the likes of Trickymatters, whose MBA told her this was going to the moon. Just some of the sad characters to have been on this board.
You're bioplar, keep changing your views according to your trade positions.
You said this a few weeks ago:
"To have 1 immunotherapy drug trial running with MSD is quite something.
To be on the verge of starting another with Merck Kgaa/ Pfizer is all the more incredible
And then to have a vaccine partnership as well with MSD"
Then a few days ago you said this company was in a death spiral, and today you are spreading negativity with funding issues etc...yet when we all know they are funded until Q4 next year. Also there are potential milestone payments coming soon, which you made no mention of. The smart money will be buying here at these prices, so yiu might not get your 50p buy in.
"It seems that some people are very angry about the SP and like to take their anger out on someone who is not prepared to mindlessly ramp the stock based on magical thinking."
Coming from you Sang, that ramps away when yiu are invested for your quick 10%. This share has huge potential for a rerate before Xmas
I have always been in the Telegram group, and still stand by the comment the ramps in their are full of BS. People are expecting shareprices of £30, £40, plus all the BS Lee comes out with to justify those prices. However we do know any buyout will be a £2bn on above based on sales of similar biotechs.
"Annnnnnd the question still stands. Just seemed like it would be a better use of time rather than triggering the same old repetition here again. Nice to know everyone is still on the buttons tho."
How is that any different to the all the ramping? That too is just a constant repetition day on day out, as there hasn't been anything new from the company. The key difference is however, all the "positive" posts are just made up on hopes, whereas the "negatives" are based on factual company performance. The last time people were saying everything was smelling of roses, it didn't quite turn out to be that way did it.
"All the cash they have is earmarked for 0518 and the Parkinsons trial."
Again another poor attempt at deramping. At no point have the company stated what they intend to use the cash for, so how have you reached this conclusion?
"Watch out for the PumpersToday 11:29
Some traders have bought in here and are desperately ramping to get their 10 per cent with talk of £2 by the end of the year."
I'd urge you all to check his posting history, he is the one of guilty of this. You will note he ramps, sells at 10%, and then comes back on here to gloat and deramps for an entry. Seems like he has sold out again and diwn desperate to get back in before the newsflow starts. £2 is not a pump. It still leaves a big bag between 4D and it's competitors on NASDAQ, who have achieved nothing. Are yiu suggesting the likes of Merck are backing a pump and dump outfit?